Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury

Abstract

The aim of the present study was to evaluate the usefulness of a closed-loop system (STG-55; Nikkiso, Tokyo, Japan), a type of artificial endocrine pancreas for the continuous monitoring and control of intraoperative blood glucose, for preventing postoperative acute kidney injury (AKI) in patients undergoing hepatectomy. Thirty-eight patients were enrolled in this study. Glucose concentrations were controlled with either a manual injection of insulin based on a commonly used sliding scale (manual insulin group, n = 19) or the programmed infusion of insulin determined by the control algorithm of the artificial endocrine pancreas (programmed insulin group, n = 19). After the induction of anesthesia, a 20-G intravenous catheter was inserted into the peripheral forearm vein of patients in the programmed insulin group and connected to an artificial endocrine pancreas (STG-55). The target range for glucose concentrations was set to 100-150 mg/dL. The mean serum creatinine concentrations of preoperative, postoperative 24 and 48 h were 0.72, 0.78, and 0.79 mg/dL in the programmed insulin group, and 0.81, 0.95, and 1.03 mg/dL in the manual insulin group, respectively. Elevations in serum creatinine concentrations postoperative 48 h were significantly suppressed in the programmed insulin group. The STG-55 closed-loop system was effective for maintaining strict blood glucose control during hepatectomy with minimal variability in blood glucose concentrations and for suppressing elevations in serum creatinine concentrations. Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative AKI.

Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study

“…Previous studies have reported that glucose variability was associated with acute kidney injury following OLT [24,27,28] which was not related directly to hyperglycemia or hypoglycemia. However, this study did not detect a difference in the requirement for dialysis postoperatively between groups but we did not measure glucose variability.…”

Control intraoperatory glucose levels with modified atlanta scheme in subtotal partial hepatectomy: Case report

“…These maneuvers generate glucose peaks due to the transition of the glycogen decomposition within hepatocytes secondary hypoxia that occurs in each pringle. [3][4][5] In addition to this, due to insulin resistance induced by liver disease per se, glucose metabolism is aggravated by hepatectomy and is not reversed during the intraoperative neohepatic stage; functional liver function then plays a decisive role in the metabolism of glucose. 6 In this case, the patient had a history of diabetes mellitus, requiring a more efficient control of glycemia.…”

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes

“…Blood was continuously sampled, and glucose levels were measured with a glucose sensor electrode and glucose oxidase membrane every minute. The pump delivering insulin and the glucose sensor electrode each had an accuracy of ±5% according to a previous report. We evaluated changes in insulin requirements from 00.00 to 08.00 hours as the “dawn phenomenon” using this artificial pancreas.…”